A systematic review of cancer risk among users of smokeless tobacco (Swedish snus) exclusively, compared with no use of tobacco.
cancer
smokeless tobacco
snus
tobacco
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
15 12 2023
15 12 2023
Historique:
revised:
19
05
2023
received:
07
12
2022
accepted:
07
06
2023
medline:
23
10
2023
pubmed:
22
7
2023
entrez:
22
7
2023
Statut:
ppublish
Résumé
The main objective of this systematic review was to assess cancer risk, and mortality after cancer diagnosis, for exclusive users of Swedish snus, compared with non-users of tobacco. We followed international standards for systematic reviews and graded our confidence in the risk estimates using the GRADE approach. Our search gave 2450 articles, of which 67 were assessed in full text against our inclusion criteria. Of these, 14 cohort-studies and one case-control study were included in the review. The studies investigated risk of cancer in the oral cavity or oropharynx (3 studies), esophagus (1 study), stomach (1 study), pancreas (2 studies), colorectum (2 studies), anus (1 study) and lung (1 study), as well as malignant lymphoma (1 study), leukemia and multiple myeloma (1 study), melanoma (1 study), any cancer (1 study) and mortality after cancer diagnosis (4 studies). Cancer risk could only be evaluated in men as there was a general lack of data for women. All included studies were evaluated to have a moderate risk of bias, mostly related to validity of exposure information. An increased risk of cancer of the esophagus, pancreas, stomach and rectum as well as an association between use of snus and increased mortality after a cancer diagnosis was reported. Our confidence in the various risk estimates varied from moderate through low to very low.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1942-1953Informations de copyright
© 2023 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Références
Collaborators GBDT. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the global burden of disease study 2019. Lancet. 2021;397:2337-2360.
General. S. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General the Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014.
Talhout R, Schulz T, Florek E, van Benthem J, Wester P, Opperhuizen A. Hazardous compounds in tobacco smoke. Int J Environ Res Public Health. 2011;8:613-628.
O'Connor R, Schneller LM, Felicione NJ, Talhout R, Goniewicz ML, Ashley DL. Evolution of tobacco products: recent history and future directions. Tob Control. 2022;31:175-182.
Folkhälsomyndigheten. Vuxnas bruk av tobaks-och nikotinprodukter. 2022 https://www.folkhalsomyndigheten.se/livsvillkor-levnadsvanor/andts/utveckling-inom-andts-anvandning-och-ohalsa/anvandning/tobaks--och-nikotinprodukters-utveckling/vuxnas-bruk-av-tobaks--och-nikotinprodukter/
Delnevo CD, Wackowski OA, Giovenco DP, Manderski MT, Hrywna M, Ling PM. Examining market trends in the United States smokeless tobacco use: 2005-2011. Tob Control. 2014;23:107-112.
Danielsson M, Lammi A, Siitonen S, Ollgren J, Pylkkanen L, Vasankari T. Alarming development of dual snus and cigarette usage among young Finnish males. BMC Public Health. 2019;19:1249.
Statistics Norway. Røyk, alkohol og andre rusmidler. 2021 https://www.ssb.no/statbank/table/07692/tableViewLayout1/
U.S. Department of Health and Human Services Centers for Disease Control and Prevention and National Institutes of Health NCI, Smokeless Tobacco and Public Health: A Global Perspective. 2014.
Osterdahl BG, Jansson C, Paccou A. Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market. J Agric Food Chem. 2004;52:5085-5088.
Hatsukami DK, Lemmonds C, Zhang Y, et al. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. J Natl Cancer Inst. 2004;96:844-852.
Tang MS, Wu XR, Lee HW, et al. Electronic-cigarette smoke induces lung adenocarcinoma and bladder urothelial hyperplasia in mice. Proc Natl Acad Sci U S A. 2019;116:21727-21731.
Lee HW, Park SH, Weng MW, et al. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proc Natl Acad Sci U S A. 2018;115:E1560-E1569.
Cochrane Handbook for Systematic Reviews of Interventionsed. 2022.
Godlee F, Malone R, Timmis A, et al. Journal policy on research funded by the tobacco industry. BMJ. 2013;347:f5193.
Tools JBICA, https://jbi.global/critical-appraisal-tools
Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383-394.
Araghi M, Galanti MR, Lundberg M, et al. Smokeless tobacco (snus) use and colorectal cancer incidence and survival: results from nine pooled cohorts. Scand J Public Health. 2017;45:741-748.
Zendehdel K, Nyren O, Luo J, et al. Risk of gastroesophageal cancer among smokers and users of Scandinavian moist snuff. Int J Cancer. 2008;122:1095-1099.
Luo J, Ye W, Zendehdel K, et al. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet. 2007;369:2015-2020.
Nordenvall C, Nilsson PJ, Ye W, Nyren O. Smoking, snus use and risk of right- and left-sided colon, rectal and anal cancer: a 37-year follow-up study. Int J Cancer. 2011;128:157-165.
Byhamre ML, Araghi M, Alfredsson L, et al. Swedish snus use is associated with mortality: a pooled analysis of eight prospective studies. Int J Epidemiol. 2021;49:2041-2050.
Araghi M, Rosaria Galanti M, Lundberg M, et al. Use of moist oral snuff (snus) and pancreatic cancer: pooled analysis of nine prospective observational studies. Int J Cancer. 2017;141:687-693.
Norwegian Institute of Public Health. Helserisiko Ved Snusbruk. (Health Risks from Snus Use). NIPH Report; 2019.
Araghi M, Galanti MR, Lundberg M, et al. No association between moist oral snuff (snus) use and oral cancer: pooled analysis of nine prospective observational studies. Scand J Public Health. 2021;49:833-840.
Roosaar A, Johansson AL, Sandborgh-Englund G, Axell T, Nyren O. Cancer and mortality among users and nonusers of snus. Int J Cancer. 2008;123:168-173.
Ye W, Ekstrom AM, Hansson LE, Bergstrom R, Nyren O. Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. Int J Cancer. 1999;83:223-229.
Fernberg P, Odenbro A, Bellocco R, Boffetta P, Pawitan Y, Adami J. Tobacco use, body mass index and the risk of malignant lymphomas: a nationwide cohort study in Sweden. Int J Cancer. 2006;118:2298-2302.
Fernberg P, Odenbro A, Bellocco R, et al. Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: a nationwide cohort study in Sweden. Cancer Res. 2007;67:5983-5986.
Odenbro A, Gillgren P, Bellocco R, Boffetta P, Hakansson N, Adami J. The risk for cutaneous malignant melanoma, melanoma in situ and intraocular malignant melanoma in relation to tobacco use and body mass index. Br J Dermatol. 2007;156:99-105.
Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health. 1994;84:399-404.
Nordenvall C, Nilsson PJ, Ye W, Andersson TM, Nyren O. Tobacco use and cancer survival: a cohort study of 40,230 Swedish male construction workers with incident cancer. Int J Cancer. 2013;132:155-161.
Wilson KM, Markt SC, Fang F, et al. Snus use, smoking and survival among prostate cancer patients. Int J Cancer. 2016;139:2753-2759.
Levitz JS, Bradley TP, Golden AL. Overview of smoking and all cancers. Med Clin North Am. 2004;88:1655-1675.
Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6. Rating the quality of evidence: imprecision. J Clin Epidemiol. 2011;64:1283-1293.
International Agency for Research on Cancer. Smokeless tobacco and some tobacco-specific N-nitrosaminesed. Vol 89. Lyon: International Agency for Research on Cancer; 2007.
Furberg H, Lichtenstein P, Pedersen NL, Bulik C, Sullivan PF. Cigarettes and oral snuff use in Sweden: prevalence and transitions. Addiction. 2006;101:1509-1515.
International Agency for Research on Cancer. Reversal of Risk after Quitting Smoking. 2007.
Engholm G, Englund A, Fletcher AC, Hallin N. Respiratory cancer incidence in Swedish construction workers exposed to man-made mineral fibres and asbestos. Ann Occup Hyg. 1987;31:663-675.
Fletcher AC, Engholm G, Englund A. The risk of lung cancer from asbestos among Swedish construction workers: self-reported exposure and a job exposure matrix compared. Int J Epidemiol. 1993;22(Suppl 2):S29-S35.
Hirsch JM, Wallstrom M, Carlsson AP, Sand L. Oral cancer in Swedish snuff dippers. Anticancer Res. 2012;32:3327-3330.
NORDCAN, https://gco.iarc.fr/media/nordcan/factsheets/92/en/countries/0/oral_cavity-20-nordcan_countries-0.pdf
Thomson B, Emberson J, Lacey B, et al. Association between smoking, smoking cessation, and mortality by race, ethnicity, and sex among US adults. JAMA Netw Open. 2022;5:e2231480.
Schaal C, Chellappan SP. Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers. Mol Cancer Res. 2014;12:14-23.
Ma B, Stepanov I, Hecht SS. Recent studies on DNA adducts resulting from human exposure to tobacco smoke. Toxics. 2019;7:7.
Hermann PC, Sancho P, Canamero M, et al. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Gastroenterology. 2014;147:1119-33e4.
Davis R, Rizwani W, Banerjee S, et al. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One. 2009;4:e7524.